GTS Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,754
Closed -$813K 1426
2026
Q1
$813K Sell
2,754
-2,640
-49% -$784K 0.03% 481
2025
Q4
$1.47M Buy
5,394
+3,172
+143% +$862K 0.05% 298
2025
Q3
$600K Buy
2,222
+887
+66% +$241K 0.02% 632
2025
Q2
$368K Sell
1,335
-186
-12% -$50.6K 0.02% 802
2025
Q1
$404K Sell
1,521
-1,518
-50% -$374K 0.02% 799
2024
Q4
$706K Buy
3,039
+666
+28% +$153K 0.03% 475
2024
Q3
$524K Sell
2,373
-8,153
-77% -$1.69M ﹤0.01% 2779
2024
Q2
$2.07M Buy
10,526
+9,548
+976% +$1.97M ﹤0.01% 1472
2024
Q1
$211K Sell
978
-12,910
-93% -$2.71M ﹤0.01% 3307
2023
Q4
$2.92M Buy
13,888
+5,320
+62% +$1.14M 0.01% 1372
2023
Q3
$1.72M Buy
8,568
+2,555
+42% +$508K ﹤0.01% 1628
2023
Q2
$1.11M Buy
+6,013
New +$1.11M 0.04% 401

Other funds holding CME

GTS Securities's CME Position: Q2 2026 in Review

GTS Securities sold out of CME Group (CME) in Q2 2026, closing a stake of 2,754 shares — an estimated $813K sold.

GTS Securities first reported a position in CME in Q2 2023 and held it in 12 quarters. The position peaked at $2.92M in Q4 2023. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GTS Securities reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 2,754 CME Group shares in Q2 2026, an estimated $813K.
  • GTS Securities first reported a position in CME Group in Q2 2023 and held it in 12 quarters.
  • GTS Securities's CME Group position peaked at $2.92M in Q4 2023.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.